These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2106887)

  • 21. [Antiviral activity of mutant interferons. A new approach to the study of structural-functional organization of interferons].
    Petrenko VA; Tat'kov SI; Sivolobova GF; Boldyrev AN; Kolokol'tsev AA
    Bioorg Khim; 1987 Feb; 13(2):259-62. PubMed ID: 3555509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
    Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
    J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Leukocyte migration inhibiting factor in preparations of alpha and gamma interferons].
    Vakhromeeva NS; Bagaeva LV; Kuznetsov VP; Medunitsyn NV; Bobkova EV
    Vopr Virusol; 1986; 31(5):617-9. PubMed ID: 3026096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation.
    François C; Bernard I; Castelain S; Charleston B; Fray MD; Capiod JC; Duverlie G
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3770-5. PubMed ID: 16127052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Design of human liposomal recombinant alpha2-interferon-containing preparation].
    Zolin VV; Kolokol'tsov AA; Agafonova OA; Bochkova TG
    Vestn Ross Akad Med Nauk; 1999; (12):18-22. PubMed ID: 10709461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of indoleamine dioxygenase by interferon in mice: a study with different recombinant interferons and various cytokines.
    Bianchi M; Bertini R; Ghezzi P
    Biochem Biophys Res Commun; 1988 Apr; 152(1):237-42. PubMed ID: 3128977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
    Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
    Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel modified beta-interferons: gene cloning, expression, and biological activity in bacterial extracts.
    Porter AG; Bell LD; Adair J; Catlin GH; Clarke J; Davies JA; Dawson K; Derbyshire R; Doel SM; Dunthorne L
    DNA; 1986 Apr; 5(2):137-48. PubMed ID: 3519136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical modification of tryptophan and histidine residues in semi-alkaline proteinase from Aspergillus melleus.
    Kobayashi S; Tazawa T; Sasaki M; Kiryu S; Sugiura M
    Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):3111-7. PubMed ID: 6440716
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative therapeutic efficacy of recombinant interferons-alpha, -beta, and -gamma against alphatogavirus, bunyavirus, flavivirus, and herpesvirus infections.
    Pinto AJ; Morahan PS; Brinton M; Stewart D; Gavin E
    J Interferon Res; 1990 Jun; 10(3):293-8. PubMed ID: 1696607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amino acid substitutions which alter the antiviral activity of human interferon-alpha 1 on mouse cells.
    Beilharz MW; Tymms MJ; Chambers PJ; McInnes B; Pitha-Rowe PM; Linnane AW
    J Interferon Res; 1988 Dec; 8(6):779-82. PubMed ID: 3148007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-alpha and -beta in kidney inflammation.
    Anders HJ; Lichtnekert J; Allam R
    Kidney Int; 2010 May; 77(10):848-54. PubMed ID: 20237459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Human enterovirus 71 (EV71) resisted type I interferon induced antiviral effect].
    Cui Y; Song J; Song QQ; Sun P; Gan X; Li GQ; Wang KX; Han J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Apr; 26(2):102-4. PubMed ID: 23002545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical modification of essential histidine residues in aspartase with diethylpyrocarbonate.
    Ida N; Tokushige M
    J Biochem; 1984 Nov; 96(5):1315-21. PubMed ID: 6396297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferons: chemical properties.
    Fantes KH
    Tex Rep Biol Med; 1981-1982; 41():240-9. PubMed ID: 6184810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of hepatitis B virus replication by interferon requires proteasome activity.
    Robek MD; Wieland SF; Chisari FV
    J Virol; 2002 Apr; 76(7):3570-4. PubMed ID: 11884582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The beta-interferon-mediated antimitogenic state resembles the anti-viral state.
    Garcia-Blanco MA; Porter JA; Morrison ED; Stiles CD
    Oncogene Res; 1990; 5(4):323-8. PubMed ID: 2204022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the in vitro host range of recombinant met-interferon-con1, interferon-alpha 2b, and interferon-beta [corrected].
    Hu CJ; Ozes ON; Klein SB; Blatt LM; Taylor MW
    J Interferon Cytokine Res; 1995 Mar; 15(3):231-4. PubMed ID: 7584668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon.
    Blatt LM; Davis JM; Klein SB; Taylor MW
    J Interferon Cytokine Res; 1996 Jul; 16(7):489-99. PubMed ID: 8836913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of antiviral activity between FeIFN-omega and FeIFN-alpha].
    Wang H; Jia X; Yang L; Sun L; Wang H; Liu W
    Sheng Wu Gong Cheng Xue Bao; 2008 Sep; 24(9):1556-60. PubMed ID: 19160837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.